Gene-targeted analysis of copy number variants identifies 3 novel associations with coronary heart disease traits

Circulation: Cardiovascular Genetics

Volumn 5, Issue 5, 2012, Pages 555-560

  Costelloe, Seán J ^a,b   El Sayed Moustafa, Julia S ^c   Drenos, Fotios ^a   Palmen, Jutta ^a   Qiao, Li ^c   Whiting, Stephen ^b   Thomas, Michael ^b   Kivimaki, Mika ^a   Kumari, Meena ^a   Hingorani, Aroon D ^a   Tzoulaki, Ioanna ^c,d   Marjo Riitta, Järvelin ^c,e,f   Aimo, Ruokonen ^e   Hartikainen, Anna Liisa ^e   Pouta, Anneli ^e,f   Walters, Robin G ^c   Blakemore, Alexandra I F ^c   Humphries, Steve E ^a   Coin, Lachlan J M ^c   Talmud, Philippa J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF IOANNINA   (Greece)

^e UNIVERSITY OF OULU   (Finland)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Apolipoproteins; Cardiovascular disease risk factors; Cardiovascular diseases; Genetic association; High density lipoprotein cholesterol

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; INTERLEUKIN 6; INTERLEUKIN 6 SIGNAL TRANSDUCER; STEROL REGULATORY ELEMENT BINDING PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADULT; ALGORITHM; ARTICLE; COPY NUMBER VARIATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC TRAIT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALGORITHMS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; COHORT STUDIES; CORONARY DISEASE; DNA COPY NUMBER VARIATIONS; GENOME, HUMAN; GENOTYPE; HUMANS; INTERLEUKIN-6; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TOLL-LIKE RECEPTOR 4;

EID: 84868615895     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.111.961037     Document Type: Article

References (47)

1. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, et al; International SNP Map Working Group. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature. 2001;409:928-933. (Pubitemid 32165347)
2. Daar AS, Scherer SW, Hegele RA. Implications of copy-number variation in the human genome: a time for questions. Nat Rev Genet. 2006;7:414. (Pubitemid 43780484)
3. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature. 2007;447:661-678.
4. Conrad DF, Andrews TD, Carter NP, Hurles ME, Pritchard JK. A high-resolution survey of deletion polymorphism in the human genome. Nat Genet. 2006;38:75-81. (Pubitemid 43011885)
5. De Smith AJ, Tsalenko A, Sampas N, Scheffer A, Yamada NA, Tsang P, et al. Array CGH analysis of copy number variation identifies 1284 new genes variant in healthy white males: implications for association studies of complex diseases. Hum Mol Genet. 2007;16:2783-2794. (Pubitemid 350048378)
6. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, et al. Global variation in copy number in the human genome. Nature. 2006;444:444-454. (Pubitemid 44809057)
7. Tuzun E, Sharp AJ, Bailey JA, Kaul R, Morrison VA, Pertz LM, et al. Fine-scale structural variation of the human genome. Nat Genet. 2005;37:727-732. (Pubitemid 41754889)
8. Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y, et al; Wellcome Trust Case Control Consortium. Origins and functional impact of copy number variation in the human genome. Nature. 2010;464:704-712.
9. McCarroll SA, Altshuler DM. Copy-number variation and association studies of human disease. Nat Genet. 2007;39(7 Suppl):S37-S42. (Pubitemid 47014474)
10. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, et al. Detection of large-scale variation in the human genome. Nat Genet. 2004;36:949-951. (Pubitemid 39167488)
11. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, et al. Large-scale copy number polymorphism in the human genome. Science. 2004;305:525-528. (Pubitemid 38971344)
12. Cambien F, Tiret L. Genetics of cardiovascular diseases: from single mutations to the whole genome. Circulation. 2007;116:1714-1724. (Pubitemid 47537846)
13. Colella S, Yau C, Taylor JM, Mirza G, Butler H, Clouston P, et al. Quan-tiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Res. 2007;35:2013-2025. (Pubitemid 47061667)
14. Illumina Inc. Bead Studio Genotyping Module v3.2 User guide. (11284301). 2007.
15. Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF, et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 2007;17:1665-1674. (Pubitemid 350074862)
16. Korn JM, Kuruvilla FG, McCarroll SA, Wysoker A, Nemesh J, Cawley S, et al. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet. 2008;40:1253-1260.
17. Coin LJ, Asher JE, Walters RG, Moustafa JS, De Smith AJ, Sladek R, et al. cnvHap: an integrative population and haplotype-based multiplatform model of SNPs and CNVs. Nat Methods. 2010;7:541-546.
18. Drenos F, Talmud PJ, Casas JP, Smeeth L, Palmen J, Humphries SE, et al. Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk. Hum Mol Genet. 2009;18:2305-2316.
19. Bauer KA, Humphries S, Smillie B, Li L, Cooper JA, Barzegar S, et al. Prothrombin activation is increased among asymptomatic carriers of the prothrombin G20210A and factor V Arg506Gln mutations. Thromb Haemost. 2000;84:396-400.
20. Benjamini Y, Yekutieli D. Quantitative trait Loci analysis using the false discovery rate. Genetics. 2005;171:783-790. (Pubitemid 43156463)
21. D'Agostino RB, Belanger A, D'Agostino RB Jnr. A suggestion for using Powerful and informative tests of normality. Am Stat. 1990;44:316-321.
22. Royston P. Constructing time-specific reference ranges. Stat Med. 1991;10:675-690.
23. Rickham PP. Human experimentation. code of ethics of the world medical association. Declaration of Helsinki. Br Med J. 1964;2:177.
24. Rose-Zerilli MJ, Barton SJ, Henderson AJ, Shaheen SO, Holloway JW. Copy-number variation genotyping of GSTT1 and GSTM1 gene deletions by real-time PCR. Clin Chem. 2009;55:1680-1685.
25. Huang RS, Chen P, Wisel S, Duan S, Zhang W, Cook EH, et al. Pop-ulation-specific GSTM1 copy number variation. Hum Mol Genet. 2009;18:366-372.
26. Harada S, Tachikawa H, Kawanishi Y. Glutathione S-transferase M1 gene deletion may be associated with susceptibility to certain forms of schizophrenia. Biochem Biophys Res Commun. 2001;281:267-271. (Pubitemid 32928147)
27. McIlwain CC, Townsend DM, Tew KD. Glutathione S-transfer-ase polymorphisms: cancer incidence and therapy. Oncogene. 2006;25:1639-1648.
28. Pae CU, Yu HS, Kim JJ, Kim W, Lee CU, Lee SJ, Jun. TY, Lee C, Paik IH, Serretti A. Glutathione S-transferase M1 polymorphism may contribute to schizophrenia in the Korean population. Psychiatr Genet. 2004;14:147-150. (Pubitemid 39281822)
29. Smith G, Stanley LA, Sim E, Strange RC, Wolf CR. Metabolic polymorphisms and cancer susceptibility. Cancer Surv. 1995;25:27-65.
30. Tchatchou S, Burwinkel B. Chromosome copy number variation and breast cancer risk. Cytogenet Genome Res. 2008;123:183-187.
31. McBride MW, Brosnan MJ, Mathers J, McLellan LI, Miller WH, Graham D, et al. Reduction of Gstm1 expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress. Hypertension. 2005;45:786-792. (Pubitemid 40418382)
32. Capoluongo E, Onder G, Concolino P, Russo A, Santonocito C, Bernabei R, et al. GSTM1-null polymorphism as possible risk marker for hypertension: results from the aging and longevity study in the Sirente Geographic Area (ilSIRENTE study). Clin Chim Acta. 2009;399:92-96.
33. Maciel SS, Pereira Ada C, Silva GJ, Rodrigues MV, Mill JG, Krieger JE. Association between glutathione S-transferase polymorphisms and tri-glycerides and HDL-cholesterol. Atherosclerosis. 2009;206:204-208.
34. Galicia JC, Tai H, Komatsu Y, Shimada Y, Akazawa K, Yoshie H. Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced. Genes Immun. 2004;5:513-516. (Pubitemid 39263887)
35. Reich D, Patterson N, Ramesh V, De Jager PL, McDonald GJ, Tandon A, et al; Health, Aging and Body Composition (Health ABC) Study. Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Am J Hum Genet. 2007;80:716-726. (Pubitemid 46564408)
36. Qi L, Rifai N, Hu FB. Interleukin-6 receptor gene variations, plasma interleukin-6 levels, and type 2 diabetes in U. S. Women. Diabetes. 2007;56:3075-3081. (Pubitemid 350223644)
37. Qi L, Rifai N, Hu FB. Interleukin-6 receptor gene, plasma C-reactive protein, and diabetes risk in women. Diabetes. 2009;58:275-278.
38. Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L. Inter-leukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J. 1998;334(Pt 2):297-314. (Pubitemid 28448572)
39. Luchtefibro M, Schunkert H, Stoll M, Selle T, Lorier R, Grote K, et al. Signal transducer of infilammation gp130 modulates atherosclerosis in mice and man. J Exp Med. 2007;204:1935-1944. (Pubitemid 47236328)
40. Geng HL, Lu HQ, Zhang LZ, Zhang H, Zhou L, Wang H, et al. Increased expression of Toll like receptor 4 on peripheral-blood mononuclear cells in patients with coronary arteriosclerosis disease. Clin Exp Immunol. 2006;143:269-273.
41. Kolz M, Baumert J, Müller M, Khuseyinova N, Klopp N, Thorand B. Association between variations in the TLR4 gene and incident type 2 diabetes is modifed by the ratio of total cholesterol to HDL-cholesterol. BMC Med Genet. 2008;9:9.
42. Takahashi N, Tsuyama N, Sasaki K, Kodaira M, Satoh Y, Kodama Y, et al. Segmental copy-number variation observed in Japanese by array-CGH. Ann Hum Genet. 2008;72(Pt 2):193-204. (Pubitemid 351228462)
43. Harding AH, Loos RJ, Luan J, O'Rahilly S, Wareham NJ, Barroso I. Polymorphisms in the gene encoding sterol regulatory element-binding factor-1c are associated with type 2 diabetes. Diabetologia. 2006;49:2642-2648. (Pubitemid 44559525)
44. Grarup N, Stender-Petersen KL, Andersson EA, Jørgensen T, Borch-John-sen K, Sandbaek A, et al. Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glyce-mia, and insulin resistance: a study of 15, 734 Danish subjects. Diabetes. 2008;57:1136-1142.
45. Hua X, Wu J, Goldstein JL, Brown MS, Hobbs HH. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Genomics. 1995;25:667-673.
46. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747-753.
47. Kathiresan S, Voight BF, Purcell S, Musunuru K, Ardissino D, Mannucci PM, et al. Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium. Genome-wide association of early-onset myo-cardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009;41:334-341.